RSV Subgroups A and B
Yes, respiratory syncytial virus (RSV) definitively exists as two distinct antigenic subgroups: RSV-A and RSV-B. These subgroups are classified based on variations in the G (attachment) glycoprotein and co-circulate simultaneously in communities with alternating patterns of dominance 1.
Molecular and Antigenic Characteristics
RSV is a single-stranded RNA virus belonging to the Pneumoviridae family. The virus is classified into RSV-A and RSV-B subtypes according to variations in the G protein, with both subgroups showing a pattern of alternative predominance between seasons 1. Multiple guidelines consistently confirm this dual subgroup structure 2.
The two subgroups contain:
- 10 genes encoding 11 proteins including attachment protein (G), fusion protein (F), and various structural and non-structural proteins
- Antigenic differences primarily in the surface G glycoprotein that define the subgroup classification 3
- Highly conserved fusion (F) protein epitopes despite sequence differences between A and B 4
Clinical Significance
Disease Severity Debate
The clinical significance between RSV subtypes remains controversial in the literature:
- Some evidence suggests RSV-A may be more virulent: A large US multicenter study found RSV-A-positive patients were more likely to require hospital or ICU admission (47.7% vs 35.8% for RSV-B, p<0.0001) 5
- However, other studies show no clinical differences: A 2017 study of 198 children found no differences between subgroups in medical history, symptoms, radiological findings, analytical results, or severity 6
- Most recent guidelines acknowledge the controversy: The 2025 Portuguese position paper states "although some studies report that RSV-A infection results in more severe outcomes, the clinical significance between the RSV subtypes remains controversial" 1
Epidemiological Patterns
Both subgroups:
- Co-circulate worldwide with shifting patterns of dominance 7
- Occur year-round but peak during cold seasons 2
- Show dynamic genotype evolution influencing epidemic patterns 7
- Can cause infections from September through May in the US 5
Diagnostic Considerations
Important caveat: Rapid antigen detection tests (RADT) show differential sensitivity between subgroups. One study demonstrated RADT sensitivity of 69% for RSV-A versus only 44% for RSV-B (p=0.001) when compared to RT-PCR 6. This limits the clinical usefulness of rapid tests for definitive diagnosis and decision-making.
Preferred diagnostic methods include:
- Nucleic acid amplification testing (NAT/RT-PCR) - highest sensitivity
- Virus isolation by cell culture
- Direct virus antigen detection 2
Reinfection Patterns
Repeat RSV infections during the same season are rare (<0.5% in clinical trials), though reinfections can occur with both heterologous and homologous strains across different seasons 3. The ability of RSV to cause reinfections throughout life is attributable to both strain variability and incomplete immune protection 3.
Vaccine Implications
Modern RSV vaccines adopt two strategies:
- Monovalent vaccines: Use stabilized prefusion F protein from RSV-A subgroup, relying on cross-protection against RSV-B
- Bivalent vaccines: Include stabilized prefusion F antigens from both RSV-A and RSV-B subgroups 4
Clinical data suggest bivalent vaccines demonstrate high efficacy against disease from both subgroups, while monovalent vaccines may show more rapid waning of RS